Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Medical Devices & Mechanical Engineering
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Hospices Civils De Lyon currently has 3 pending office actions in the Medical Devices & Mechanical Engineering technology area. These actions are distributed across 3 distinct art units, which indicates a broad technical scope for their current filings. The portfolio involves a distinct examiner for each action, meaning that every pending case is reviewed by a different official.
LYNCH, ROBERT A is the busiest examiner, currently overseeing 1 pending office action. This specific examiner's role is part of a larger group of 3 distinct examiners within the Medical Devices & Mechanical Engineering sector. The distribution across 3 distinct art units requires a versatile legal strategy to address the unique requirements of each unit. With 1 pending action under the busiest examiner, the company must ensure consistency across its diverse filings to achieve favorable outcomes in all active matters.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (33%) |
| §103 only | 1 (33%) |
| §112 only | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LYNCH, ROBERT A | 1 | 80.3% | +12.9% |
| SALVOZA, M FRANCO G | 1 | 68.4% | +30.0% |
| ADAMS, MICHELLE | 1 | 58.6% | +40.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18567531 | FENESTRATED ENDOPROSTHESIS OF THE THORACIC AORTA | LYNCH, ROBERT A | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17918184 | METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-ASSOCIATED INFECTION IN A PATIENT | SALVOZA, M FRANCO G | 34d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17918184 | METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-ASSOCIATED INFECTION IN A PATIENT | SALVOZA, M FRANCO G | 34d |
| 18567531 | FENESTRATED ENDOPROSTHESIS OF THE THORACIC AORTA | LYNCH, ROBERT A | — |
| 17762664 | FLUORESCENT PROBE AND APPLICATIONS THEREOF | ADAMS, MICHELLE | — |
| Art Unit | Apps |
|---|---|
| 3771 | 1 |
| 1672 | 1 |
| 1797 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18567531 | FENESTRATED ENDOPROSTHESIS OF THE THORACIC AORTA | LYNCH, ROBERT A | 3771 | §103 | Final Rejection | — | Pending | Dec 06, 2023 |
| 17918184 | METHOD FOR DETERMINING THE RISK OF INCIDENCE OF A CARE-ASSOCIATED INFECTION IN A PATIENT | SALVOZA, M FRANCO G | 1672 | §101§103§112 | Non-Final OA | 34d | Pending | Mar 02, 2023 |
| 17762664 | FLUORESCENT PROBE AND APPLICATIONS THEREOF | ADAMS, MICHELLE | 1797 | §112 | Final Rejection | — | Pending | Mar 22, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial